Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss

Credit: UNSPLASH/CC0 Public Domain Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with more weight or obesity than only the use of tirzepatide treatment. Endo 2025Annual meeting of Endocrine Society at San Francisco, California. Research Fellow, for the division of endocrinology at the Mayo Clinic…

Read More

Fed holds firm

Welcome to The Hill’s Business & Economy newsletter {Beacon} Business & Economy Business & Economy The Big Story Fed keeps rates unchanged The Federal Reserve declined to cut interest rates on Wednesday amid President Trump’s fight to exert more influence over the independent central bank. © AP Federal Open Market Committee (FOMC)… Source link

Read More

exports growth beats estimates as imports recover

A cargo ship carries foreign trade containers on the Jiaozhou Bay waterway in Qingdao, Shandong Province, China, on August 5, 2025. Costfoto | Nurphoto | Getty Images China’s exports growth in July sharply beat market expectations as the clock on a tariff truce with the U.S. keeps ticking, while imports rose their highest jump in…

Read More

New Target CEO Michael Fiddelke faces challenges

People walk by a Target store in midtown Manhattan in New York City, March 21, 2025. Kylie Cooper | Reuters When Target’s new CEO Michael Fiddelke steps into the role in early February, he will inherit a company facing slumping sales, faltering customer loyalty and skeptical investors. Its fiscal second-quarter results posted Wednesday illustrated the…

Read More

FDA approves first weight-loss GLP-1 pill

Click for more news from The Hill {Beacon} Health Care Wegovy’s Big Story Pill version could expand access The FDA has approved the first pill version of the blockbuster GLP-1 drug for weight loss, a move that could significantly expand access to the treatment, though the full cost is unclear. ©AP… Source link

Read More